The mold metabolite cytochalasin B blocked transmission through the perfused superior cervical sympathetic ganglion of the cat. Acetylcholine injected close-arterially during block continued to excite the ganglion cells so that failure was presynaptic and, by inference, due to reduced output of acetylcholine from the preganglionic nerves. This blocking effect of cytochalasin was reduced by pyruvate. It is concluded that cytochalasin inhibits cholinergic nervous function and it does so, at least in part, by depressing energy production at some stage before pyruvate formation. One possibility is a block of glucose uptake for which there is evidence from other cell types. A more general conclusion is that inhibitory effects of cytochalasin on other secretory systems may also involve such a metabolic component and do not necessarily reflect an interaction of the drug with microfilaments as has been commonly supposed.
Recently, there has been conjecture that some contractile process is involved in the release of secretory products from various cells. More specifically, the suggestion has been made that microtubules or microfilaments participate in the phenomenon of exocytosis (1) . Several workers have found support for the idea in the inhibitory effects on various secretory systems of two types of drug: on the one hand the alkaloids colchicine and vinblastine that disrupt microtubules; and, on the other, the mold metabolite, cytochalasin B, which Wessels et al. (2) suggested owed its varied pharmacological effects to a corresponding action disrupting microfilamentous function.
However, pharmacological analysis is commonly beset by problems of unspecificity, and this certainly complicates studies with colchicine. For example, perhaps the most striking inhibitory effect of that alkaloid on any secretory process, inhibition of adrenal medullary secretion to cholinomimetic agents (3), appears on analysis (4-6) not to involve the extrusion process proper as supposed-for this can still be elicited by other stimuli-but some earlier stage in stimulus-secretion coupling as yet undefined. In the present report, our main purpose is to draw attention to a corresponding complication in studies with cytochalasin that has come to light during the course of experiments on its effects on nervous secretion. Nerves and related cells were among the first secretory cells to be found sensitive to cytochalasin, the drug inhibiting output of vasopressin from the terminals of the hypothalamoneurohypophyseal tract (5), norepinephrine from sympathetic fibers (7) , and catecholamines from the developmentally homologous chromaffin cells (5) . In each instance, the result * Address reprint requests to this author.
prompted speculation on the possible involvement of microfilaments in the secretory process. We have now extended this survey to cholinergic nerves and found comparable inhibitory effects of cytochalasin. However, our analysis indicates the effect is, at least in part, the result of some inhibitory effect of the drug on energy production.
METHODS AND MATERIALS
Ganglion Preparation. Adult cats, male or female, were anesthetized with sodium pentobarbital (25 mg/kg, injected intraperitoneally) followed by chloralose (50 mg/kg, injected intravenously). One superior sympathetic ganglion was dissected for perfusion by the now classical method introduced by Kibjakow (8) and modified by Feldberg and Gaddum (9) and Birks and MacIntosh (10) . Perfusion fluid entered the common carotid artery through a long polyethylene cannula and escaped through a cannula in the main vein draining the ganglion region. All blood vessels not supplying the ganglion were tied, including the fine vessels running in the postganglionic sympathetic trunk. Perfusion was thus restricted to the ganglion. A cannula placed in the central stump of the lingual artery allowed retrograde injection of acetylcholine-containing solutions designed to test the responsiveness of the ganglion cells. The procedure was to inject 0.3 ml of Locke's solution containing 50 ug/ml of acetylcholine and terminate stimulation by withdrawing 0.5 ml through the same cannula after 30 sec. The volume injected corresponded to about half the volume of the carotid cannula and was less than that flowing through the ganglion in this same period. The (11) . Pyruvate Locke's solution was similar but with the addition of 5 mM sodium pyruvate.
Drugs. Cytochalasin B, purchased from Imperial Chemical Industries, Mereside, Alderly Park, Macclesfield, Cheshire, England, was prepared in a stock solution (50 mg/ml) in (CH3)2SO and added to the perfusion medium to yield a final concentration of (CH3)2SO of 0.1%. (CH3)2SO in this concentration had no obvious effects on ganglionic transmission, but to simplify interpretation all the other perfusion media (Locke's or pyruvate Locke's) also contained 0.1% (CH3)2SO.
RESULTS
CoAtinuous electrical stimulation of the preganglionic trunk caused a rapid rise of tension in the nictitating membrane that reached a peak value within a few seconds and, after subsiding briefly to some lower value, rose again to be sustained at some intermediate level for many minutes. When cytochalasin (50 ,gg/ml) was introduced to the perfusion stream tension fell, after a brief delay, to some lower value. This blocking effect of cytochalasin was relatively small in initial tests on freshly prepared ganglia but on successive trials it always increased, and complete or near-complete block was then regularly achieved. Failure of transmission during each exposure to cytochalasin generally occurred in two phases: the first progressing rapidly, the second more slowly. This is illustrated particularly well in the lower left record of Fig. 1 where a notch in the declining record of tension is plainly visible. During the fully developed block it was still possible, however, in each of several experiments, to elicit contraction of the nictitating membrane by close-arterial injection of acetylcholine into the ganglion. Such responses, although slightly less than those Fig. 1 , lower records, and involved exposure to cytochalasin B (50 gg/ml) during each of three successive periods of preganglionic stimulation (10 V, 0.5 msec, 20 Hz). Sodium pyruvate (5 mM) was present during the second exposure to cytochalasin and the response was thus bracketed by control responses to cytochalasin before (A) and after (B). The tension developed by the nictitating membrane after 10-min exposure to cytochalasin was compared with the tension developed immediately before the drug was introduced to yield the value for % inhibition of transmission. The difference between the responses during exposure to pyruvate and the mean of the paired controls before (A) and after (B) is highly significant (*P < 0.01). (horizontal arrow). Cytochalasin, introduced for the period indicated, caused almost complete failure that is slowly reversible on withdrawing the drug. Note that acetylcholine still elicites a response during this block. The lower traces show three successive responses to cytochalasin (50;zg/ml). In the second, Na pyruvate (5 mM) was added along with the cytochalasin. Note the antagonism of inhibition; also, in the lefthand record, the biphasic course of block; and, in the central record, the relative inefficacy of pyruvate in countering the initial fast phase of block. ACh, acetylcholine.
obtained before stimulation, indicated that the inhibitory effect of cytochalasin was mainly preginglionic (Fig. 1, upper  record) . In seeking an explanation for the increasing efficacy of cytochalasin after repeated trials involving prolonged stimulation, we considered that it might be associated with diminishing supplies of endogenous energy substrates (12) . This hypothesis prompted tests of the effects of augmenting the energy substrates in the perfusion medium. Raising the glucose concentration to 20 or 50 mM did not antagonize the inhibition produced by cytochalasin, but the addition of pyruvate (5 mM) did. Pyruvate was selected because it is known to sustain acetylcholine synthesis in nervous tissue (13) (14) (15) and, indeed, has been shown to be a fairly effective substitute for glucose in maintaining transmission in this same ganglion preparation (15) . Altogether four trials of pyruvate were made, the substance being introduced simultaneously with cytochalasin. The most striking response is illustrated in Fig. 1 (lower records) , and the complete results are presented in Table 1 . In no experiment did pyruvate, given in this way, appreciably diminish the initial rapid phase of block. Its main effect was generally to arrest and reverse the course of the second phase.
DISCUSSION
It is evident that cytochalasin can produce profound block of transmission in the cervical sympathetic ganglion and that much of this effect, to judge from the persistence of ganglionic Physiology: Nakazato and Douglas responses to intra-arterial injection of acetylcholine, is preganglionic and, by inference, the result of diminished output of acetylcholine from the preganglionic nerves. Cholinergic nerves can thus be added to the list of secretory cells whose function can be disrupted by cytochalasin. Since the ganglion cells and their axons in the ganglionic region continue to respond, if not maximally at least vigorously, during exposure to cytochalasin it is unlikely that the profound presynaptic lesion is referable to loss of the electrical properties of the fibers. While we cannot rule this out it is more probable, in the light of comparable inhibitory effects of cytochalasin on closely related secretory preparations, that failure results primarily from some interference with the mechanisms involved in the release of acetylcholine. Thus, cytochalasin also inhibits secretion in the adrenal chromaffin cell, which is developmentally related to the ordinary neurones but where impulse generation is not involved (5); moreover, the drug inhibits secretion of posterior pituitary hormones from the nerve endings of the hypothalamo-neurohypophyseal tract not only in response to electrical stimulation but also to direct depolarization with excess K+ (5) .
Whether the blocking effect of cytochalasin indicates any involvement of microfilaments in the secretory process, as suggested in the earlier studies (5, 7), is far from certain. Subsequent to this earlier work evidence has come to light that cytochalasin is capable of blocking the entry into several cells of various hexoses, including 2-deoxyglucose which is transported by the same mechanism as glucose (16) (17) (18) . The blocking effect of cytochalasin may thus reflect interference with glucose uptake and, consequently, energy production. Our finding that block is countered by pyruvate, at least partially, supports this view. Such an explanation would harmonize with our observation that cytochalasin-induced block increases with repeated and prolonged stimulation during which it seems reasonable to suppose endogenous energy sources (12) are being depleted and the preparation becoming increasingly dependent on extracellular glucose. We found that in fresh preparations, where the blocking effect of cytochalasin is relatively small, withdrawal of glucose from the perfusion medium for many minutes (30-60) slightly reduces transmission (unpublished data), as already noted by others (12, 15) , whereas after prolonged stimulation, when cytochalasin has intense blocking effects, omission of glucose causes failure quite readily. Moreover, failure of ganglionic transmission after withdrawal of glucose results primarily from a presynaptic lesion involving diminished acetylcholine output (12, 15) , as seems also to occur with cytochalasin.
Although we interpret our experiments to mean that cytochalasin can depress cholinergic function by inhibiting energy production at some stage earlier than pyruvate formationpossibly by an inhibitory effect on glucose uptake such as occurs in certain other cells (16) (17) (18) , we do not advance this as the sole explanation for block. Indeed our results suggest to us that cytochalasin may have more than one action: two phases of block were clearly discernable in most of our experiments, the first is rapid in onset and the second develops more slowly. Moreover, pyruvate had only a partial restorative effect, and this was restricted to the slow phase. But whether the pyruvate-insensitive component has anything to do with microfilaments can only be guessed at.
Although there remains the task of assessing how much of the inhibitory effect of cytochalasin on nervous function is attributable to depression of energy production from glucose, there seems little doubt that such an action is involved. Furthermore, a comparable metabolic action of the drug seems also to contribute to its complex effects on growth hormone secretion (19) . One of us (W.W.D.) and Y. Ueda (unpublished experiments) have observed that histamine release from mast cells is inhibited powerfully by cytochalasin B only when glycolysis is rate-limiting. Considered together with the demonstrated ability of cytochalasin to inhibit hexose transport (16) (17) (18) , all this provides sufficient reason for rejecting the notion that functional changes induced by cytochalasin in secretory cells-or indeed any other cell typeconstitute proof of involvement of microfilaments.
A further, more restricted, conclusion from the present results is that the inhibitory effects of cytochalasin B on electrically-evoked output of norepinephrine from the vas deferens may not be due to an action of the adrenergic terminals as originally proposed (7) , but to block of transmission through the ganglionic relays demonstrated by several authors (20, 21 
